1. Vitamin B6 prevents Isocarbophos-induced posterior cerebral artery injury in offspring rats through up-regulating S1P receptor expression.
- Author
-
Liu Y, Yang K, Wang L, Yang J, Wang Y, Luo H, Li P, and Yin Y
- Subjects
- Acid-Base Equilibrium drug effects, Animals, Apoptosis drug effects, Caspase 3 metabolism, Cerebral Arterial Diseases pathology, Cytokines metabolism, Disease Models, Animal, Female, Hypoxia chemically induced, Hypoxia prevention & control, Insecticides toxicity, Lysophospholipids metabolism, Malathion analogs & derivatives, Malathion toxicity, Male, Malondialdehyde blood, Malondialdehyde metabolism, Maternal Exposure adverse effects, Nitric Oxide blood, Nitric Oxide metabolism, Paternal Exposure adverse effects, Posterior Cerebral Artery injuries, Posterior Cerebral Artery pathology, Protective Agents therapeutic use, Rats, Sprague-Dawley, Sphingosine analogs & derivatives, Sphingosine metabolism, Superoxide Dismutase blood, Superoxide Dismutase metabolism, Up-Regulation, Vasoconstriction drug effects, Vitamin B 6 therapeutic use, Rats, Cerebral Arterial Diseases prevention & control, Posterior Cerebral Artery drug effects, Protective Agents pharmacology, Sphingosine-1-Phosphate Receptors metabolism, Vitamin B 6 pharmacology
- Abstract
We have previously reported that the long-term exposure of Isocarbophos, a kind of organophosphorus compounds, induces vascular dementia (VD) in rats. Studies have also shown that organophosphorus compounds have adverse effects on offsprings. Vitamin B6 is a coenzyme mainly involved in the regulation of metabolism and has been demonstrated to ameliorate VD. Sphingosine-1-phosphate (S1P), a biologically active lipid, plays a vital role in the cardiovascular system. However, whether S1P is involved in the therapeutic effects of Vitamin B6 on posterior cerebral artery injury has yet to be further answered. In the present study, we aimed to explore the potential influence of Vitamin B6 on Isocarbophos-induced posterior cerebral artery injury in offspring rats and the role of the S1P receptor in this process. We found that Vitamin B6 significantly improves the vasoconstriction function of the posterior cerebral artery in rats induced by Isocarbophos by the blood gas analysis and endothelium-dependent relaxation function assay. We further demonstrated that Vitamin B6 alleviates the Isocarbophos-induced elevation of ICAM-1, VCAM-1, IL-1, and IL-6 by using the enzyme-linked immunosorbent assay kits. By performing immunofluorescence and the western blot assay, we revealed that Vitamin B6 prevents the down-regulation of S1P in posterior cerebral artery injury. It is worth noting that Fingolimod, the S1P inhibitor, significantly inhibits the Vitamin B6-induced up-regulation of S1P in posterior cerebral artery injury. Collectively, our data indicate that Vitamin B6 may be a novel drug for the treatment of posterior cerebral artery injury and that S1P may be a drug target for its treatment., (© The Author(s) 2021. Published by Oxford University Press on behalf of the Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2021
- Full Text
- View/download PDF